Respirerx Pharmaceuticals Incis A Biopharmaceutical Company Dedicated To Developing Innovative Therapies For Neurologicalpsychiatricand Respiratory Disorders Linked To Disrupted Neuronal Signalingthe Company Aims To Address Conditions With Limited Treatment Optionssuch As Obstructive Sleep Apneaosa Attention Deficit Hyperactivity Disorderadhd Epilepsychronic Painand Spinal Cord Injuryscirespirerx Operates Through Two Main Drug Development Platformsthe Resolutionrx Platform Focuses On Pharmaceutical Cannabinoidswith Its Lead Candidatedronabinolbeing Repurposed For Osa Treatmentthe Endeavourrx Platform Includes Ampakines And Gabakineswhich Are Designed To Enhance Synaptic Communication And Target Conditions Like Chronic Pain And Epilepsythe Company Is Actively Conducting Clinical Trials And Researchincluding A Department Of Defense Funded Study On Ampakines For Respiratory Recovery And Preclinical Work On Gabakines As Non Opioid Analgesics
